Antiserum and Polyclonal antibodies are the focus of his Antibody studies. He merges Biochemistry with Genetics in his study. He performs multidisciplinary studies into Genetics and Biochemistry in his work. Many of his studies on Endocrinology apply to Hydroxyproline as well. His Internal medicine study frequently intersects with other fields, such as Immunohistochemistry. His study on Immunohistochemistry is mostly dedicated to connecting different topics, such as Internal medicine. His research on Procollagen peptidase frequently connects to adjacent areas such as Molecular biology. His work in Molecular biology is not limited to one particular discipline; it also encompasses Procollagen peptidase. His study deals with a combination of Enzyme and Chromatography.
Juha Risteli incorporates Internal medicine and Surgery in his studies. Juha Risteli conducts interdisciplinary study in the fields of Surgery and Internal medicine through his research. Juha Risteli carries out multidisciplinary research, doing studies in Biochemistry and Genetics. He performs integrative study on Genetics and Biochemistry. Endocrinology is closely attributed to Procollagen peptidase in his work. His study in N-terminal telopeptide extends to Enzyme with its themes. While working in this field, he studies both N-terminal telopeptide and Bone resorption. Juha Risteli incorporates Bone resorption and Bone remodeling in his research. He integrates Bone remodeling and Osteoporosis in his research.
His study focuses on the intersection of Effects of high altitude on humans and fields such as Anatomy with connections in the field of Genitourinary system and Joint hypermobility. His Genitourinary system study frequently links to adjacent areas such as Anatomy. In most of his Physical therapy studies, his work intersects topics such as Hypermobility (travel) and Joint hypermobility. His research is interdisciplinary, bridging the disciplines of Physical therapy and Hypermobility (travel). Juha Risteli integrates Internal medicine with Gastroenterology in his study. Juha Risteli undertakes interdisciplinary study in the fields of Gastroenterology and Internal medicine through his research. He integrates Biochemistry with Animal science in his research. Borrowing concepts from Biochemistry, he weaves in ideas under Animal science. His research on Endocrinology frequently links to adjacent areas such as Procollagen peptidase.
In his research, Joint hypermobility is intimately related to Physical therapy, which falls under the overarching field of Hypermobility (travel). Joint hypermobility is closely attributed to Physical therapy in his study. In his papers, he integrates diverse fields, such as Biochemistry and Animal science. Juha Risteli performs multidisciplinary study in the fields of Animal science and Biochemistry via his papers. His research on Internal medicine often connects related areas such as Procollagen peptidase. The study of Procollagen peptidase is intertwined with the study of Internal medicine in a number of ways. His research combines Type I collagen and Endocrinology. Type I collagen is closely attributed to Endocrinology in his research. His study ties his expertise on Gene expression together with the subject of TLR9.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation.
Juha Risteli;Inkeri Elomaa;Seija Niemi;Anne Novamo.
Clinical Chemistry (1993)
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.
J Melkko;S Niemi;L Risteli;J Risteli.
Clinical Chemistry (1990)
Mannose receptor-mediated regulation of serum glycoprotein homeostasis.
Sena J. Lee;Stefan Evers;Daniel Roeder;Albert F. Parlow.
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
P Garnero;M Ferreras;MA Karsdal;R Nicamhlaoibh.
Journal of Bone and Mineral Research (2003)
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
Erik F. Eriksen;Peder Charles;Flemming Melsen;Leif Mosekilde.
Journal of Bone and Mineral Research (2009)
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
J Risteli;S Niemi;P Trivedi;O Mäentausta.
Clinical Chemistry (1988)
Biochemical Markers of Bone Metabolism
Leila Risteli;Juha Risteli.
Annals of Medicine (1993)
Immunoassay for intact amino-terminal propeptide of human type I procollagen.
J Melkko;S Kauppila;S Niemi;L Risteli.
Clinical Chemistry (1996)
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells
B Smedsrød;J Melkko;L Risteli;J Risteli.
Biochemical Journal (1990)
Aberrant type I and type III collagen gene expression in human breast cancer in vivo
Saila Kauppila;Frej Stenbäck;Juha Risteli;Arja Jukkola.
The Journal of Pathology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: